Business · 04/02/2020Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Promotional Labeling and Advertising for Prescription Biological Products
Summary
The Food and Drug Administration (FDA) has published a draft guidance document to help pharmaceutical companies develop compliant promotional materials for prescription biological products, including reference and biosimilar medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →